Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Which Aristocrat ETF Minimizes Taxes In Retirement compares options to help you minimize tax drag in retirement.
22,003 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As Sempra wraps up the 2025 fiscal year, investors want clarity on the Q4 2025 earnings trajectory. This article brea...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
Eight leading real estate lead generation firms rise to the top in 2026, offering AI powered insights, exclusive lead...
Playnance reports Be The Boss has delivered over $2 million in real payouts and grown to 2,809 active Bosses, as it p...
Apple sticks to an asset-light model with robust buybacks, while Microsoft escalates capital spending to fuel AI and ...
Tech-led losses push the Nasdaq lower as investors weigh rates and policy risks. Markets remain volatile as traders m...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
A trio of megacaps—NVIDIA, Alphabet, and Amazon—has caught the eye of stocks wall street analysts as the era of AI fu...
Ripple unveils a plan to add on-chain lending to the XRP Ledger, potentially broadening XRP's role beyond payments. T...
OpenAI wins a Pentagon deal to deploy its AI in classified systems as Anthropic is designated a supply chain risk by ...